The design of new antimalarial combinations to treat Plasmodium falciparum infections requires drugs that, in addition to resolving disease symptoms caused by asexual blood stage parasites, can also interrupt transmission to the mosquito vector. Gametocytes, which are essential for transmission, develop as sexual blood stage parasites in the human host over 8-12 days and are the most accessible developmental stage for transmission-blocking drugs. Considerable effort is currently being devoted to identifying compounds active against mature gametocytes.
INTRODUCTION
Plasmodium falciparum malaria remains a primary global cause of death and disability from infectious disease, particularly in infants and pregnant women (1).
Malaria treatment currently relies on artemisinin-based combination therapy (ACT), however, emerging resistance to artemisinins in the field (2, 3) underscores the need to progress new antimalarial candidates through the drug development pipeline.
Recent in vitro high throughput screening (HTS) campaigns against P. falciparum asexual blood stages, the forms responsible for the clinical manifestations of the disease, have identified a wealth of active chemical classes, representing a promising starting point for the discovery of new therapeutic agents (4-7). The current malaria elimination strategy has also highlighted the need for all new antimalarial combination therapies to include components capable of interrupting the transmission of sexual stage gametocytes to Anopheles mosquitoes (8, 9). Methods to enable prioritization of inhibitors of the asexual parasite stages based on their additional transmission-blocking activity are therefore urgently required.
P. falciparum gametocytes develop through five morphologically distinct stages in
incubated under standard conditions of 37°C in a gas mixture of 5% O 2 , 5% CO 2 , 90% N 2 . Asexual parasitemia was maintained at approximately 2% by regular dilution of cultures using uninfected RBCs (Fig. 1A) . Five days before the induction of gametocytogenesis the NF54 Pfs16 parasites were synchronized at the ring stage by two rounds of exposure to 5% D-sorbitol for 10 minutes, performed 8 hr apart (24) (Fig. 1B) .
Induction and purification of early stage gametocytes. The approach used to stimulate gametocytogenesis was based on the method first described by Fivelman and colleagues (25), modified to increase yield. To maximize the stage homogeneity of the parasites undergoing the gametocytogenesis induction process, 24 hr before the application of stress (on day -3 of gametocytogenesis, five days after the first sorbitol synchronization) trophozoite cultures were magnetically purified using a MACS ® column (Miltenyi Biotech) (26) . The column-retained trophozoites were eluted and resuspended in fresh RBCs to a final parasitemia of 3% and a decreased hct of 1.25% (Fig. 1C) . The cultures were gently shaken overnight to minimize the number of multiply-infected RBCs. The following day generally yielded a high ring parasitemia (average 9.95% ± SEM 0.23%; n = 13). Cultures then received a partial medium change consisting of 3/4 of the total culture volume (day -2, Fig. 1D ), and the hct was increased to 2.5%. After a further 24 hr incubation, the stressed parasites at the trophozoite stage were allowed a full medium change and the parasitemia was reduced to 3% (day -1, Fig. 1E ). Cultures were incubated overnight on a shaker. The ring stage cultures obtained the following day (day 0 of gametocytogenesis), which included gametocytes beginning to differentiate, were then separated from all other parasite stages by an additional round of magnetic purification. This purification step removed the later stage gametocytes that had formed spontaneously before the induction process, as well as asexual trophozoites and schizonts that had lost synchronicity, thus enriching for very early stage gametocytes resulting from the standardized induction method only. The flowthrough fraction typically yielded ~12% parasitemia (average 11.94% ± SEM 0.33%; n = 10). The cultures were resuspended at 1.25% hct into blasticidin-free malaria culture medium supplemented with 0.5 g/L glucose, as well as 50 mM N-acetyl-Dglucosamine (NAG) to prevent reinvasion of asexual parasites (27) (Fig. 1F ), and were incubated overnight.
Assay development and optimization. On day one of gametocytogenesis the medium was replaced and the hct level was adjusted according to experimental requirements. The parasites, typically at 10% parasitemia (average 9.96% ± SEM 0.72%; n = 10) were plated without further RBC addition to a final volume of 50 μL per well in sterile 384-well white plates (CulturPlate®, PerkinElmer) using a Multidrop (Thermo Scientific) reagent dispenser under sterile conditions. The plates were then barcoded as appropriate, sealed with gas-exchange membranes (Breathe-Easy®, Sigma-Aldrich) and incubated at standard conditions for 72 hr (Fig. 1G ). The luminescence activity was measured on day 4 of gametocytogenesis ( Fig. 1H ), using the Steadylite plus™ (PerkinElmer) luminescence reporter gene assay system on a MicroBeta® Trilux multidetector luminometer.
The effect of hct level and gametocyte numbers on the luciferase signal was measured to determine the optimal conditions for a linear response. On day one of gametocytogenesis, two independent cultures were plated at 0.17%, 0.46% and 1.25% hct values at their original parasitemia and after a 1:8 dilution with uninfected
RBCs. Three more cultures were kept at 0.5% hct and serially diluted (1: 2.6) five times using uninfected RBC. All cultures were plated in 12 replicate wells. After the incubation, 20 µL per well of Steadylite was added and the luminescence signal from the gametocyte density and hct range plates was measured following 1 and 4 hr incubations at room temperature, respectively.
DMSO tolerance was assessed on gametocyte cultures plated into five groups of 24 wells at 0.5% hct in 8 increasing concentrations of DMSO (0.1% to 6.4%), on day 1 of gametocytogenesis. At the end of the incubation, 20 µL per well of Steadylite was added and the luminescence signal was measured after a one-hour incubation at room temperature. The experiments were repeated 2 to 6 times.
To compare the intensity of the luminescence signal from gametocytes to the background signal, two independent gametocyte cultures on day one of gametocytogenesis were plated at 0.5% hct into two groups of 24 replicate wells containing either 0.4% DMSO (negative control, maximum signal) or 2 µM puromycin (positive control, background signal). At the end of the incubation, 20 µL of Steadylite was added and the luminescence signal was measured at three different time points, namely 15 minutes, 2.5 hr and 5 hr after the addition of the luciferase substrate. The average maximum and background signals, as well as the signal-to-noise ratio, were calculated for each time point.
Final assay conditions. Experimental compounds were added to the plates at various concentrations, typically in a volume of 5 μL and a final DMSO concentration of 0.4%. Two full columns of each plate were used as in-plate controls, and contained 0.4% DMSO (negative control, 0% inhibition) and 5 μM puromycin (positive control, 100% inhibition), respectively. Gametocyte cultures were then added to the compound-containing plates at 0.5% hct in a volume of 45 µL per well on day one of gametocytogenesis, and sealed with gas-exchange membranes as described above. At the end of the 72 hr incubation, on day 4 of gametocytogenesis, 25 μL of medium was removed from each well and replaced with 15 μL of Steadylite, using a Biomek® FX high throughput liquid handling system (Beckman Coulter). The plates were light protected and incubated at room temperature for 60 minutes to allow for complete cell lysis, after which time the luminescence signal was measured. Giemsa smears were taken from parallel gametocyte cultures, These known antimalarials were also tested in parallel against 3D7 and NF54 Pfs16 asexual stages, using our imaging-based HTS assay (28 Compounds were then diluted 1:8 in 100% DMSO then 1:25 in water, to obtain 50 µM solutions in 4% DMSO. The diluted compounds were dispensed into the assay plates, as described above, to give a final assay compound concentration of 5 µM.
The first two columns in each plate were used for the in-plate negative (0.4% DMSO) and positive (5 µM puromycin) controls.
Primary screening was performed in 3 doses (5, 2.5 and 0.5 µM) and hits were defined as compounds inhibiting early gametocyte development by ≥50% at the highest dose. The hits were cherry-picked from the source plates, serially diluted as described above and tested in 16-point dose-response format, at a concentration range of 0.05 nM -5 µM.
Eleven exemplar compounds from the MMV Malaria Box were then retested in parallel on NF54 Pfs16 gametocytes and on 3D7 and NF54 Pfs16 asexual stages as described above (n = 2, single point), to compare their respective activities. The experiment was carried out on a separate occasion using a new batch of the MMV Malaria Box. The results were related to the asexual activity data made available by MMV for the Malaria Box compounds, which consist of two P. falciparum 3D7 datasets (23), one generated from our laboratory using the same imaging approach employed in this current study (the "Avery" dataset) (28) , and the other derived from ChEMBL (the "ChEMBL" dataset). In addition, to check whether the measured inhibitory activity might be due to a direct luciferase enzymatic inhibition or quenching by the compounds, we also carried out an "artefact" test. For this a single gametocyte culture plate was incubated without treatment for 72 hr in standard conditions. The selected compounds and the luciferase substrate were then added to the plate, and the luciferase activity was measured 1.5 hr later, without extended compound exposure. Assay development and optimization. Variations in the hct and gametocytemia levels were explored to assess their effects on the luciferase signal and to determine the optimal values for the assay. A hct increase from 0.2% to 0.5% resulted in a mean ± SD increase of 2.10 ± 0.18 fold in the luminescence signal at every gametocytemia level tested (ANOVA p < 0.001; n = 4), due to the increased number of gametocytes in the same volume of culture. A further increase of hct to 1.25%, while also resulting in an increased luminescence signal at low gametocytemia levels (2.30 ± 0.42 fold increase; n = 2) did not provide readout improvements at gametocytemia levels of 2.6% or above (1.03 ± 0.14 fold change; n = 2; Fig. 2A ). As these measurements were carried out after a long incubation time following luciferase kit addition (4 hr), it is unlikely that the observed saturation was caused by incomplete cell lysis at high hct values. Given the saturation effect observed at higher values, a hct level of 0.5% was chosen for the assay setup. The choice was further justified by the fact that a strong linear correlation existed between the luminescence signal and gametocyte numbers at each hct level tested, in particular R 2 = 0.99 for all three independent cultures at 0.5% hct (Fig. 2B ). This demonstrates the reliability of this readout system to obtain an accurate estimation of gametocyte numbers in the samples.
RESULTS

Our
Next, the threshold of parasite tolerance to DMSO, the solvent used to dilute most test compounds, was determined. Early stage gametocytes were found to tolerate DMSO up to 0.8%, a concentration that did not reduce the intensity of the luminescence signal compared to DMSO-free controls after a 72 hour incubation (t test p = 0.787; n = 4; Fig. 3 ). To remain well below this threshold, a final DMSO concentration of 0.4% was adopted for subsequent experiments and screening activities.
The quality of the luciferase signal was assessed by calculating the signal to noise ratio (S:N) (30), based on the measurement of the luciferase activity of gametocytes exposed to 0.4% DMSO (0% gametocyte inhibition, maximum signal) and 5 µM puromycin (100% inhibition, background noise; Fig. 4 ). Both the signal and the background were shown to remain relatively stable over 5 hr after the addition of the Steadylite kit. The average signals from DMSO-and puromycin-treated gametocytes from both cultures showed a similar trend, with an increase at 2.5 hr most likely due to the completion of cell lysis, followed by a slight decrease due to the slow luciferase signal decay (Fig. 4 ). The S:N of the two cultures remained in the same range for the entire duration of the experiment: 64.3 and 47.3, respectively, at 15 min, and 39.7 and 43.9 respectively, 5 hr after the kit addition.
The suitability of the assay for HTS was determined using the Z' factor, a dimensionless statistical parameter combining the difference between maximal signal and background, and their respective variations (30) . The Z' factor can range between -∞ and 1, and a value ≥ 0.5 generally indicates a good assay (30) . At gametocytemia values above 0.1%, the Z' factor remained consistently above 0.7 (Fig. 5) , whereas lower parasite densities resulted in less predictable Z' values.
Taken together, the DMSO tolerance, S:N and Z' indicated good assay performance and predicted useful flexibility regarding the initial gametocytemia that can be used in the assay.
To ascertain whether the luciferase assay response reflected the actual cell viability in the samples, a comparison between the luciferase readout and manual gametocyte counting by microscopy was performed using the same puromycin treated gametocyte culture. The half inhibitory concentration (IC 50 ) values of 59.7 nM (95% confidence interval 56.2 -63.4 nM) and 93.9 nM (95% confidence interval 53.2 -165.7 nM) obtained using the luciferase approach and manual counting via microscopy, respectively, showed good agreement between the two methods ( Fig.   6 ). Not surprisingly, the luciferase assay displayed much less variability than manual counting of Giemsa smears, given the subjectivity and lower precision of the latter method.
HTS campaigns often involve large numbers of plates simultaneously prepared throughout the various stages of the assay (e.g. fixation/lysis, placement on stacker at room temperature etc.), however it is not uncommon for the final reading to be undertaken over a period of many hours. For luciferase HTS assays it is therefore critical to determine the time interval between the addition of the luciferase kit / lysis of the cells and the actual reading, that still allows a reliable luciferase measurement.
In this study the consistency of the IC 50 values over time was determined using puromycin and dihydroartemisinin, which showed IC 50 values of 86.1 ± 3.2 nM and 3.1 ± 0.3 nM, respectively, at the first reading carried out 44 -50 minutes after kit addition. Fig. 7 shows the extended window of time available for the final assay reading after the luciferase kit was added to the plates. The IC 50 values obtained by reading the same plates multiple times over a period of 7.5 hr did not show statistically significant differences (ANOVA p = 0.218 and 0.996 for puromycin and dihydroartemisinin, respectively). The Z' values calculated from the in-plate negative (0.4% DMSO) and positive (5 µM puromycin) control wells remained in the 0.7 -0.8 range throughout the repeated readings (Fig. 7) . asexual stages (Table 1) .
The compounds tested exerted a remarkably similar inhibitory activity on the asexual stages of the two related parasite lines. The mean ± SEM IC 50 ratio for NF54 Pfs16 / 3D7 for the compounds corresponded to 1.43 ± 0.09. In striking contrast, stage I-III NF54 Pfs16 gametocytes were completely insensitive to three compounds, and showed more than a 5-fold reduced sensitivity than the asexual stages of both parasite lines to eight other compounds in our parallel tests. The observed differences appeared to be dependent on the chemical class of the drugs.
Endoperoxides (artemisinin, artemisone, artemether, artesunate and artenimol) and aminoalcohols (mefloquine, lumefantrine, halofantrine, but not quinine) were equally effective on the two parasite forms, while the other classes showed a generally weaker gametocytocidal activity.
MMV Malaria Box screening. The early stage gametocytocidal assay was then used to screen the MMV Malaria Box (23). The 'biased' nature of this chemical library, consisting of 400 known P. falciparum asexual stage actives, was anticipated to affect the statistical distribution of the screening data, with an expectation of high numbers of compounds affecting early stage gametocytes. Indeed, the activity distribution at the highest dose (5 µM) deviated strongly from normality (Fig. 8A, 8B ).
To obtain a statistically appropriate hit cutoff, the luciferase signal from 9 negative control plates (0.4% DMSO) and 2 positive control plates (5 µM puromycin) was measured. The data from the control plates (3456 data points) showed a clearly normal distribution (Fig. 8C, 8D) , with median % inhibition of 0.58% and median absolute deviation (MAD) of 3.14%. A corresponding robust hit cutoff (median % inhibition + 3 x MAD) of 10% inhibition was obtained. However, having verified the statistical boundaries for a reliable cutoff value, we selected only compounds with activity ≥ 50%, as compounds exhibiting less activity at 5 µM are unlikely to be attractive for progression.
The primary screening of the MMV Malaria Box revealed that only 135 of the 400 compounds, i.e. ~1/3 of the whole library, inhibited early gametocytogenesis by ≥ 50% at the highest concentration of 5 µM (Table 2) Box (four drug-like and two probe-like), which had shown no gametocytocidal activity on the first screening, were also included in this confirmation experiment to act as asexual stage selective controls (Table 4 ).
Ten out of the 11 compounds showed excellent agreement in their activity on 3D7
between our test and both publicly available asexual stage datasets. Moreover, the activity on NF54 Pfs16 asexual stages was found to overlap with the reference asexual data and our 3D7 data for seven compounds of the selected set. Among the remaining four compounds, the drug-like GNF-Pf-3245 showed a greatly reduced activity on all the cultures tested, as opposed to its 220 nM gametocytocidal activity from the screening and the reported asexual data, possibly due to compound degradation during storage / handling. The compounds SJ000091710, GNF-Pf-4188
and GNF-Pf-3159 exhibited weaker inhibition on the NF54 Pfs16 line in respect to 3D7, a finding that could possibly reflect a reduced sensitivity of the recombinant line to the compounds.
As with our reference drug set, the selected MMV Malaria Box compounds showed differing inhibition profiles on gametocytes and asexual stages ( As with any in vitro screening report, the compound activity data produced in this study will benefit from additional studies to confirm activity, as confounding factors may exist. A general limitation of in vitro studies is that compounds requiring metabolic activation in the host, such as primaquine (47), are likely to be overlooked.
The use of different technologies, namely luciferase and imaging, for gametocytes and asexual stages, respectively, has to be taken into account for potential biases.
The impact of these different approaches on the estimated inhibitory potencies, Drug-like compounds Table S1 ). The dotted line indicates the limit beyond which statistically valid IC 50 values could not be obtained for early stage gametocytes. ** correspond to statistically significant difference with p < 0.0001 
